Axa’s PharMerica Corporation PMC Stock Holding History

Axa’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-70,500	Closed	-$2.01M	–	1547
2015 Q3	$2.01M	Sell	70,500 -8,700	-11%	-$292K	0.01%	776
2015 Q2	$2.64M	Buy	79,200 +4,300	+6%	+$132K	0.01%	736
2015 Q1	$2.11M	Sell	74,900 -13,483	-15%	-$335K	0.01%	794
2014 Q4	$1.83M	Buy	88,383 +27,400	+45%	+$650K	0.01%	817
2014 Q3	$1.49M	Sell	60,983 -14,517	-19%	-$385K	0.01%	825
2014 Q2	$2.16M	Sell	75,500 -17,300	-19%	-$481K	0.01%	756
2014 Q1	$2.6M	Buy	92,800 +400	+0.4%	+$9.82K	0.01%	694
2013 Q4	$1.99M	Buy	92,400 +8,900	+11%	+$162K	0.01%	766
2013 Q3	$1.11M	Buy	83,500 +15,600	+23%	+$210K	0.01%	851
2013 Q2	$941K	Buy	+67,900	New	+$962K	0.01%	854

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Axa's PMC Position: Q4 2015 in Review

Axa sold out of PharMerica Corporation (PMC) in Q4 2015, closing a stake of 70,500 shares — an estimated $2.01M sold.

Axa first reported a position in PMC in Q2 2013 and held it in 10 quarters. The position peaked at $2.64M in Q2 2015. 195 funds tracked by Wall St. Rank hold PMC as of Q4 2015.

Axa reported no remaining PharMerica Corporation position as of Q4 2015 after selling out during the quarter.
Axa sold 70,500 PharMerica Corporation shares in Q4 2015, an estimated $2.01M.
Axa first reported a position in PharMerica Corporation in Q2 2013 and held it in 10 quarters.
Axa's PharMerica Corporation position peaked at $2.64M in Q2 2015.
195 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2015.

Based on Axa's 13F filing for Q4 2015, filed 12 Feb 2016.